Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05490329 · ClinicalTrials.gov registry record · NA
Addressing Vaccine Hesitancy and Increasing COVID-19 Vaccine Uptake Among African American Young Adults in the South
A NA study, sponsored by Florida State University.
- Completed
- Registry status
- NA
- Development phase
- 360
- Enrollment target
NCT05490329 is a NA study that has completed, run by Florida State University. The registered enrollment target is 360 participants.
The verdict
NCT05490329, a NA study, has completed, sponsored by Florida State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 360 participants
- Enrollment target
Study Summary
The study staff will conduct a hybrid type 1 effectiveness implementation 2-arm trail with 360 Black young adults from Alabama, Georgia, and North Carolina. Participants will be randomized to receive the standard of care (control) or the TT-C intervention arm, each with a balance of 180 participants. Primary effectiveness outcome is COVID-19 vaccine uptake define as receipt of any vaccine (primary series or secondary booster). Secondary effectiveness outcomes are vaccine hesitancy, confidence, and knowledge, attitudes, and beliefs. The study staff will also conduct qualitative interviews with a group of purposively selected AA-YA participants (est. n=12-16) and site staff (est. n=6-8) to assess barriers and facilitators to implementation. The hypothesis is that the intervention arm will be more effective than the control arm at increasing vaccine uptake.
Interventions
- BEHAVIORAL Tough Talks COVID
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 360 participants |
| Start Date | 2023-03-13 |
| Est. Completion | 2024-06-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05490329
The ClinicalTrials.gov registry entry for NCT05490329 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 360 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Florida State University, which has 219 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Tough Talks COVID is the first listed.
NCT05490329 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05490329 about?
NCT05490329 is a clinical study titled "Addressing Vaccine Hesitancy and Increasing COVID-19 Vaccine Uptake Among African American Young Adults in the South". The study staff will conduct a hybrid type 1 effectiveness implementation 2-arm trail with 360 Black young adults from Alabama, Georgia, and North Carolina. Participants will be randomized to receive the standard of care (control) or the TT-C intervention arm, each with a balance of 180 participants...
What is the current status of trial NCT05490329?
This trial is currently completed. It is a NA study. The enrollment target is 360 participants. The study started on 2023-03-13. Estimated completion is 2024-06-15.
What interventions are being tested in trial NCT05490329?
The interventions under investigation include: Tough Talks COVID (BEHAVIORAL).
Who is sponsoring clinical trial NCT05490329?
This trial is sponsored by Florida State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.